

Author: Agardh E. Hultberg B. Agardh C.-D.
Publisher: Informa Healthcare
ISSN: 0036-5513
Source: Scandinavian Journal of Clinical and Laboratory Investigation, Vol.60, Iss.3, 2000-06, pp. : 169-174
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The vascular-injuring amino acid homocysteine was previously shown to be increased in plasma in type 1 diabetic patients with clinical signs of nephropathy. Previous studies have also shown an inconsistent relationship between the development of diabetic nephropathy and retinopathy, indicating different pathogenetic mechanisms. In this study, plasma homocysteine was measured in 25 type 1 diabetic patients with a well-characterized form of severe retinopathy. Furthermore, a group of 24 type 1 diabetic patients with similar age at onset of diabetes and diabetes duration with no or minimal background retinopathy were investigated, in order to determine whether plasma homocysteine levels are different from those in patients with severe retinopathy. Patients with severe retinopathy did not have higher plasma levels of homocysteine (13.9 μmol/L; 5.9-30.7, median and range) than those without retinopathy (10.4 μmol/L; 5.7-18.9). Within the group of patients with severe retinopathy, increased homocysteine levels were confined to the patients (19.9 μmol/L; 10.0-30.7, n=9) with serum creatinine levels >100 μmol/L, compared to those patients (9.6; 5.9-14.3 μmol/L, n=15) with a serum creatinine below 100 μmol/L. None of the patients without or with minimal background retinopathy had serum creatinine levels >100 μmol/L. We conclude that diabetic retinopathy is not associated with increased plasma homocysteine levels, but plasma homocysteine accumulates, probably owing to reduced glomerular filtration, in diabetic patients with signs of nephropathy. In these patients, the promoting effect of nephropathy on the development of retinopathy does not seem to be mediated through homocysteine.
Related content








Choroidal thickness in diabetic patients without diabetic retinopathy
ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. :